Abstract
Introduction. Fibroblast growth factor-23 (FGF-23) is a marker that indicates the process of bone mineral disorders in chronic kidney disease dialysis. An elevated FGF-23 causes a remodeling process that contributes to the development of left ventricle hypertrophy (LVH) and the still controversial direct decline of left ventricle ejection fraction (LVEF) among hemodialysis patients. This study aimed to seek out the connection between FGF-23 levels in serum with left ventricle hypertrophy and left ventricle ejection fraction among regular hemodialysis patients.
Methods. A cross-sectional study was conducted to 111 regular hemodialysis patients for twice a week in Cipto Mangunkusumo Hospital in Jakarta from July to September 2023. The Mann Whitney and chi square tests were subsequently used to evaluate the difference as well as the connection between FGF-23 levels with LVH and LVEF.
Results. Among the 111 subjects, the median serum intact fibroblast growth factor-23 (iFGF-23) level was 536.20 pg/mL (IQR, 135.80–2,180.10). Echocardiographic findings showed that 94 subjects (84.68%) had LVH, while 17 (15.32%) did not. An LVEF of
Conclusions. FGF-23 levels were significantly lower in patients with LVH than in those without LVH. These findings suggest that FGF-23 may have potential as a marker for evaluating LVH.
Bahasa Abstract
Pendahuluan. Fibroblast growth factor-23 (FGF-23) merupakan penanda proses gangguan mineral tulang pada penyakit ginjal kronik dialisis. Peningkatan FGF-23 menyebabkan proses remodelling yang berkontribusi pada perkembangan hipertrofi ventrikel kiri (left ventricular hypertrophy/LVH) dan penurunan fraksi ejeksi ventrikel kiri (left ventricular ejection fraction/LVEF) secara langsung pada pasien hemodialisis (HD) masih menjadi kontroversi. Tujuan penelitian untuk mengetahui hubungan kadar FGF-23 dalam serum dengan LVH dan LVEF pada pasien HD regular.
Metode. Studi potong lintang dilakukan terhadap 111 pasien hemodialisis regular dua kali seminggu di Rumah Sakit Dr. Cipto Mangunkusumo (RSCM) Jakarta selama periode Juli sampai September 2023. Uji Mann Whitney dan Chi square digunakan untuk menilai perbedaan serta hubungan kadar FGF-23 dengan LVH dan LVEF.
Hasil. Dari total 111 subjek, didapatkam kadar rerata iFGF-23 536,20 pg/ml (RIK 135,80 – 2180,10). Didapatkan hasil ekokardiografi gambaran LVH 84,68% dan tidak LVH 15,32%. Didapatkan hasil LVEF
Kesimpulan. Kadar FGF-23 lebih rendah pada pasien dengan hipertrofi ventrikel kiri dibandingkan pasien tanpa hipertrofi ventrikel kiri. Dengan demikian kadar FGF-23 dapat berpotensi menjadi penanda untuk mengevaluasi hipertrofi ventrikel kiri sesuai dengan hasil penelitian.
Kata Kunci: FGF-23, fraksi ejeksi ventrikel kiri, hemodialisis, hipertrofi ventrikel kiri
Recommended Citation
Silalahi, Ester Morina Ester; Marbun, Maruhum Bonar; Ginanjar, Eka; and Shatri, Hamzah
(2026)
"Hubungan Kadar Fibroblast Growth Factor-23 dalam Serum dengan Hipertrofi Ventrikel Kiri dan Fraksi Ejeksi Ventrikel Kiri pada Pasien Hemodialisis di Rumah Sakit Cipto Mangunkusumo,"
Jurnal Penyakit Dalam Indonesia: Vol. 13:
Iss.
3, Article 4.
DOI: 10.7454/jpdi.v13i3.1850
Available at:
https://scholarhub.ui.ac.id/jpdi/vol13/iss3/4